Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by hmmmmmmmmon Nov 30, 2022 3:11pm
281 Views
Post# 35140742

RE:RE:Infomed Negotiations Ongoing?

RE:RE:Infomed Negotiations Ongoing?On April 8 2021 Spectral announced a 20yr exclusive license deal for DIMI. It was clearly material information and the stock moved around 13% to .57 on that information.

I think any investor would expect that Spectral would have disclosed that they had not met conditions of the licensing agreeement in June.
But, they did not disclose until they were forced to by the extra oversight and lawyers that surrounds a raise- so they withheld until October.

Will they release a MOU? With their track record, I'd say not a chance.. But we as investors are all watching, and they are creating a very public record. I would hope the board and leagal concil would demand disclosure on changes to previously announced licensing deals.
<< Previous
Bullboard Posts
Next >>